Consolidated revenues of $111.0 billion increased 8%. Earnings per diluted share of $10.44 increased $1.52. Adjusted Earnings per Diluted Share of $11.68 increased 18%. Generated $3.1 billion of cash ...
These efforts reflect a shared commitment to apply AI thoughtfully to reduce complexity and strengthen the systems patients rely on. The healthcare system’s intricate web of tasks and processes often ...
Approve, download and pay all pharmaceutical product purchases with the payables management module in the McKesson Connect online ordering platform for pharmacies. View, approve, download, print and ...
Oncologists are treating nearly twice as many patients with cell and gene therapies (CGTs) as they were in 2024, and 97% say CGTs could offer some patients the best chance for a cure. This year, the ...
Pharmacies operate within a complex environment of contracts, credentialing requirements, rules and reimbursement systems that few outside the industry ever see. Pharmacy Services Administrative ...
At LogiPharma USA 2026, McKesson leaders Chris Van Norman and Nicole Wade participated in the panel, “Racing to Meet the Moment: Supply Chains Built for Today’s Therapies.” The discussion highlighted ...
The proposed payment change could reshape how 340B hospitals evaluate high-cost, clinic-administered therapies. Health systems may need greater visibility into reimbursement, acquisition costs, and ...
McKesson is investigating a cybersecurity incident involving third-party applications and unauthorized access and exfiltration of data. McKesson supplies medical equipment, pharmaceuticals, and health ...
Consolidated revenues of $97.8 billion increased 23%. Earnings per diluted share of $6.25 decreased $0.75. Adjusted Earnings per Diluted Share of $8.26 increased 5%. McKesson completed the ...
Read time: 2 minutes By: McKesson Health Systems Editorial Team As more health systems add specialty pharmacies to their in-house offerings, partnering with the right pharmacy services administrative ...
IRVING, Texas, November 5, 2025 - McKesson Corporation (NYSE:MCK) today announced results for the second quarter ended September 30, 2025. Quarterly consolidated revenues increased to a record high of ...
NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 — CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results